Genesys Capital (“Genesys”) is pleased to announce the upcoming closing of Genesys Ventures IV LP (“Fund IV” or the “fund”) to continue its successful track record of building Canadian life science companies in both the medtech and biotech sectors.
June 11, 2025
Genesys Capital (“Genesys”) is pleased to announce the upcoming closing of Genesys Ventures IV LP (“Fund IV” or the “fund”) to continue its successful track record of building Canadian life science companies in both the medtech and biotech sectors.
Venture Ontario
Suite 3001
250 Yonge St.
Toronto, ON M5B 2L7
